AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519 | +60.2% | 21,006 | +83.4% | 0.00% | – |
| Q2 2023 | $324 | -4.7% | 11,454 | -22.8% | 0.00% | – |
| Q1 2023 | $340 | -99.9% | 14,834 | -6.2% | 0.00% | -100.0% |
| Q3 2022 | $447,000 | +106.0% | 15,807 | +61.1% | 0.00% | – |
| Q2 2022 | $217,000 | +55.0% | 9,810 | +130.3% | 0.00% | – |
| Q4 2021 | $140,000 | -56.5% | 4,260 | -25.5% | 0.00% | – |
| Q3 2021 | $322,000 | -20.1% | 5,715 | -21.9% | 0.00% | – |
| Q2 2021 | $403,000 | -30.2% | 7,322 | -45.1% | 0.00% | -100.0% |
| Q4 2020 | $577,000 | +761.2% | 13,337 | +596.4% | 0.00% | – |
| Q3 2020 | $67,000 | -42.2% | 1,915 | -12.3% | 0.00% | – |
| Q2 2020 | $116,000 | -86.7% | 2,183 | -91.9% | 0.00% | -100.0% |
| Q3 2019 | $875,000 | +1051.3% | 27,037 | +2286.3% | 0.00% | – |
| Q1 2019 | $76,000 | -84.8% | 1,133 | -89.6% | 0.00% | -100.0% |
| Q4 2018 | $501,000 | +47.4% | 10,875 | +146.2% | 0.00% | 0.0% |
| Q3 2018 | $340,000 | -83.6% | 4,418 | -82.1% | 0.00% | -87.5% |
| Q2 2018 | $2,078,000 | +56.6% | 24,678 | +52.0% | 0.01% | -86.2% |
| Q1 2018 | $1,327,000 | +232.6% | 16,234 | +132.1% | 0.06% | +241.2% |
| Q4 2017 | $399,000 | +19850.0% | 6,994 | +18802.7% | 0.02% | – |
| Q3 2017 | $2,000 | -85.7% | 37 | -89.5% | 0.00% | -100.0% |
| Q4 2016 | $14,000 | -99.0% | 354 | -98.7% | 0.00% | -99.0% |
| Q3 2016 | $1,473,000 | +186.0% | 27,905 | +126.9% | 0.10% | +194.1% |
| Q2 2016 | $515,000 | +27.8% | 12,301 | +23.8% | 0.03% | +6.2% |
| Q1 2016 | $403,000 | +5657.1% | 9,933 | +8109.1% | 0.03% | +3100.0% |
| Q4 2015 | $7,000 | -94.4% | 121 | -89.3% | 0.00% | -90.0% |
| Q2 2015 | $125,000 | +792.9% | 1,130 | +782.8% | 0.01% | +400.0% |
| Q4 2014 | $14,000 | – | 128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |